Vivo Capital, LLC Ascendis Pharma A/S Transaction History

Vivo Capital, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$78.08 - $117.61 $23.1 Million - $34.9 Million	-296,477 Reduced 67.0%	146,025 $13.6 Million
Q4 2021 Feb 11, 2022	SELL	$127.1 - $169.66 $40.4 Million - $54 Million	-318,104 Reduced 41.82%	442,502 $59.5 Million
Q3 2021 Nov 15, 2021	SELL	$112.67 - $176.92 $86.3 Million - $135 Million	-765,753 Reduced 50.17%	760,606 $121 Million
Q2 2021 Aug 16, 2021	SELL	$121.62 - $145.29 $16.8 Million - $20 Million	-137,883 Reduced 8.29%	1,526,359 $201 Million
Q1 2021 May 17, 2021	SELL	$124.92 - $173.33 $16.7 Million - $23.1 Million	-133,503 Reduced 7.43%	1,664,242 $214 Million
Q2 2020 Aug 14, 2020	SELL	$110.87 - $156.01 $22.8 Million - $32 Million	-205,402 Reduced 10.25%	1,797,745 $266 Million
Q1 2020 May 15, 2020	BUY	$97.01 - $145.11 $194 Million - $291 Million	2,003,147 New	2,003,147 $226 Million
Q3 2019 Nov 13, 2019	SELL	$95.8 - $118.9 $197 Million - $245 Million	-2,060,135 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$107.11 - $132.09 $1.42 Million - $1.76 Million	13,303 Added 0.65%	2,060,135 $237 Million
Q1 2019 May 14, 2019	SELL	$62.15 - $129.99 $7.46 Million - $15.6 Million	-120,000 Reduced 5.54%	2,046,832 $241 Million
Q1 2018 May 15, 2018	BUY	$38.98 - $68.04 $15.6 Million - $27.2 Million	400,000 Added 22.64%	2,166,832 $142 Million
Q3 2017 Nov 13, 2017	BUY	$26.89 - $37.1 $47.5 Million - $65.5 Million	1,766,832	1,766,832 $64 Million

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.